Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

AIMS: There are concerns regarding increased risk of acute coronary syndrome with dabigatran. We aimed to assess whether alternative treatment options such as rivaroxaban or apixaban carry a similar risk as compared with dabigatran. METHODS: We searched MEDLINE and EMBASE for randomized controlled t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Clin Pharmacol
Hauptverfasser: Loke, Yoon K, Pradhan, Shiva, Yeong, Jessica Ka-yan, Kwok, Chun Shing
Format: Artigo
Sprache:Inglês
Veröffentlicht: BlackWell Publishing Ltd 2014
Schlagworte:
Reviews
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239965/
https://ncbi.nlm.nih.gov/pubmed/24617578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12376
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge